Oncolytics Biotech Inc Com NPV
Sell:0.00pBuy:0.00p
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:0.00p
Buy:0.00p
Change:No change
No changePrices delayed by at least 15 minutes
Sell:0.00p
Buy:0.00p
Change:No change
No changePrices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 August 2025 | Jared Ryan KellyCEO | Buy Regular purchase transaction | 23,500 | $0.86 | $20,280.50 | 73,900 |
| 17 July 2025 | Thomas C HeinemanOther Level A | Buy Regular purchase transaction | 15,000 | $1.27 | $19,050.00 | 148,102 |
| 17 July 2025 | Allison HagermanVice President | Buy Regular purchase transaction | 4,600 | 1.71 CAD | 7,866.00 CAD | 67,875 |
| 16 July 2025 | Jared Ryan KellyCEO | Buy Regular purchase transaction | 50,400 | $1.19 | $60,061.68 | 50,400 |
| 15 July 2025 | Kirk J. LookCFO | Buy Regular purchase transaction | 12,800 | $1.17 | $14,976.00 | 150,065 |
| 15 July 2025 | Andrew P AromandoChief Level Officer | Buy Regular purchase transaction | 25,500 | $1.19 | $30,237.90 | 25,500 |
| 21 April 2025 | Deborah M BrownDirector | Sell Tax related | 17,080 | 0.79 CAD | 13,493.20 CAD | 58,083 |
| 21 April 2025 | James Todd ParsonsDirector | Sell Tax related | 15,152 | 0.79 CAD | 11,970.08 CAD | 8,103 |
| 29 January 2025 | Matthew CoffeyPresident/CEO | Sell Tax related | 43,548 | 1.08 CAD | 47,031.84 CAD | 163,006 |
| 29 January 2025 | Kirk J. LookCFO | Sell Tax related | 58,893 | 1.08 CAD | 63,604.44 CAD | 137,265 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 29 January 2025 | Kirk J. LookCFO | Sell Tax related | 58,893 | 1.08 CAD | 63,604.44 CAD | 137,265 |
| 16 July 2025 | Jared Ryan KellyCEO | Buy Regular purchase transaction | 50,400 | $1.19 | $60,061.68 | 50,400 |
| 29 January 2025 | Thomas C HeinemanOther Level A | Sell Tax related | 54,324 | 1.08 CAD | 58,669.92 CAD | 133,102 |
| 29 January 2025 | Matthew CoffeyPresident/CEO | Sell Tax related | 43,548 | 1.08 CAD | 47,031.84 CAD | 163,006 |
| 15 July 2025 | Andrew P AromandoChief Level Officer | Buy Regular purchase transaction | 25,500 | $1.19 | $30,237.90 | 25,500 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.